Who
Brad Hively
Director
Company insider
Files Form 4 as: Chief Executive Officer, Starling Oncology.
In numbers
- Trades disclosed
- 52
- Buys
- 4
- Sells
- 7
- Bought
- $107K
- Sold
- $9.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Jan 2021
- Last trade
- 21 Aug 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Aug 2026filed 24 Aug 2026 | STLN Starling OncologyProviders & Facilities | SEC FORM 4 Sold | $1.9M298,853 at $6.51 | filing |
| 21 Aug 2026filed 24 Aug 2026 | STLN Starling OncologyProviders & Facilities | SEC FORM 4 Sold | $1.9M298,853 at $6.51 | filing |
| 27 Jul 2026filed 29 Jul 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —27,108 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —27,108 at $0.00 | filing |
| 15 Dec 2025filed 16 Dec 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Sold | $50K13,333 at $3.77 | filing |
| 20 Nov 2025filed 24 Nov 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —41,667 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —32,407 at $0.00 | filing |
| 19 Aug 2025filed 21 Aug 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Sold | $82K20,221 at $4.06 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology Instituteoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —684,528 at $0.00 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology Instituteoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —105,320 at $0.00 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology Instituteoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —131,297 at $0.00 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology Instituteoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —946,460 at $0.00 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code M | $582K684,528 at $0.85 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code M | $51K105,320 at $0.48 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code M | $246K131,297 at $1.87 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code M | $804K946,460 at $0.85 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Sold | $5.4M1,867,605 at $2.87 | filing |
| 3 Jun 2025filed 5 Jun 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Sold | $311K108,532 at $2.87 | filing |
| 26 Mar 2025filed 28 Apr 2025 | The Oncology Instituteoption or derivative · Providers & Facilities | SEC FORM 4 Code P | $2,94322,640 at $0.13 | filing |
| 26 Mar 2025filed 28 Apr 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $47K45,280 at $1.04 | filing |
News
No headline names them, or the companies they trade most, lately.